Liver Cirrhosis Therapeutics - Pipeline Assessment And Market Forecasts To 2017

Liver Cirrhosis Therapeutics - Pipeline Assessment And Market Forecasts To 2017

By:


GlobalData estimated the global liver cirrhosis market to be valued at $1.56 billion in 2010. It is expected to grow to $2.03 billion with a Compound Annual Growth Rate (CAGR) of 3.8% by 2017. This growth is primarily attributed to the increasing prevalence of the disease due to increase in alcoholic liver disease, nonalcoholic steatohepatitis (NASH) and the large group of patients who were originally infected with hepatitis virus, who will be entering their third decade of chronic liver infection.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Liver-Cirrhosis-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2017&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report

GlobalData analyzed that the available treatment options are moderately successful in meeting the market demand. Liver cirrhosis treatment is a supportive treatment and hence the drugs aim at treating the complications of the disease. Thus treatment of cirrhosis includes preventing further damage to the liver, treating the complications of cirrhosis and preventing liver cancer or detecting it early. There are drugs available for each of the complications and these off-label drugs have good safety and efficacy profiles. It is because of this that the unmet need is low even though there are no approved drugs for liver cirrhosis. However, there is still scope available for new entrants with new disease-modifying mechanisms of action, increased clinical performance and high safety profiles. There is scope for new entrants which will aim at reversal of the disease and increasing the survival rates because liver cirrhosis is a leading cause of morbidity and mortality worldwide.

GlobalData analyzed that there are seven molecules in various stages of the pipeline. Lucassin, AST-120, HPN-100, and Copegus plus Pegasys are some of the late stage pipeline molecules. The market is dominated by off-label products and these molecules target the complications for which there are presently no approved therapies. These emerging therapies are likely to intensify the competition in the liver cirrhosis market as they have to compete with the generics.

GlobalData, the industry analysis specialists new report, Liver Cirrhosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global liver cirrhosis therapeutics market. The report identifies the key trends shaping and driving the global liver cirrhosis therapeutics market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global liver cirrhosis therapeutics sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Liver-Cirrhosis-Therapeutics-Pipeline-Assessment-and-Market-Forecasts-to-2017&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.globaldata.com

For more details contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782


About the Author:
GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage including oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.



Article Originally Published On: http://www.articlesnatch.com


|

Loading...
Related....
Videos...

Recent Health Articles

Comments

Still can't find what you are looking for? Search for it!

Loading

Copyright 2005-2011 ArticleSnatch, LLC - All Rights Reserved.
Privacy Policy | Terms of Service.